Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

7,854 total articles

Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness
Apr 22, 2026
Nina Shah
Press Releases

Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness

Incannex Healthcare Inc. announced its PSX-001 program aligns with a recent White House Executive Order aimed at accelerating the approval and availability of psychedelic treatments for serious mental illnesses. The company highlighted strong Phase 2 clinical trial results for PSX-001, its oral synthetic psilocybin therapeutic targeting Generalized…

IXHL
Axe Compute Secures $260 million, Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment
Apr 22, 2026
Hana Yamamoto
Press Releases

Axe Compute Secures $260 million, Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment

Axe Compute Inc. announced a significant 36-month enterprise contract valued at approximately $260 million to deliver a dedicated cluster of 2,304 NVIDIA B300 GPUs and AI-focused high-speed storage at a Tier 3 US data center. This largest engagement in the company's history will support large-scale AI model training, fine-tuning, and inference task…

AGPU
Arcutis’ ZORYVE® (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines
Apr 22, 2026
Sofia Navarro
Press Releases

Arcutis’ ZORYVE® (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines

Arcutis Biotherapeutics announced that ZORYVE® (roflumilast) cream has received a strong recommendation with high certainty of clinical evidence in the American Academy of Dermatology's first-ever guidelines for pediatric atopic dermatitis treatment. The guidelines endorse ZORYVE cream for children aged 2 years and older, highlighting its efficacy,…

ARQT
Preferred Bank Reports First Quarter Results
Apr 22, 2026
Derek Hwang
Press Releases

Preferred Bank Reports First Quarter Results

Preferred Bank reported net income of $31.1 million ($2.53 per diluted share) for Q1 2026, a slight increase year-over-year but a decrease compared to the prior quarter. The results were impacted by a reversal of interest income due to a large loan relationship placed on nonaccrual status, rate cuts by the Federal Reserve, and lower noninterest inc…

PFBC
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
Apr 22, 2026
Priya Menon
Press Releases

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

Corbus Pharmaceuticals announced that updated clinical data for CRB-701, a next-generation Nectin-4 antibody-drug conjugate for oncology indications, will be presented at ASCO 2026. The data includes efficacy and safety in head and neck squamous cell carcinoma (HNSCC) and cervical cancer patients. The company plans to start a registrational study i…

CRBP
Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Apr 22, 2026
Hana Yamamoto
Press Releases

Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

Immutep Limited announces that a clinical abstract on its immunotherapy drug eftilagimod alfa has been accepted for poster presentation at the ASCO 2026 Annual Meeting. The data highlights the drug’s ability to activate lymphocytes rapidly and sustain immune response, with markers correlating to improved overall survival in metastatic cancer patien…

IMMP
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
Apr 22, 2026
Priya Menon
Press Releases

Humacyte Appoints Jim Mercadante as Chief Commercial Officer

Humacyte, Inc., a Nasdaq-listed biotechnology company specializing in bioengineered human tissues, has appointed Jim Mercadante as Chief Commercial Officer. With over 25 years of healthcare commercial experience, Mercadante will lead the expansion of Symvess, the company's first FDA-approved acellular tissue engineered vessel (ATEV), currently mark…

HUMA
LiveOne (Nasdaq: LVO) Eliminates $15M+ Short-Term Liabilities, Delivering $13M+ in Cash Savings; Expands Stock Conversion Program to $15M+ at $7.50 per Share, with $8M Completed
Apr 22, 2026
Avery Klein
Press Releases

LiveOne (Nasdaq: LVO) Eliminates $15M+ Short-Term Liabilities, Delivering $13M+ in Cash Savings; Expands Stock Conversion Program to $15M+ at $7.50 per Share, with $8M Completed

LiveOne (Nasdaq: LVO) announced strategic financial milestones including elimination of $15 million+ short-term liabilities, resulting in over $13 million in cash savings. The company also expanded its stock conversion program to over $15 million at $7.50 per share, with $8 million already completed, enhancing financial stability and supporting lon…

LVO
Las Vegas Metropolitan Police Signs Five-Year WrapReality™ Contract Renewal with WRAP® to Advance Immersive Training and Non-Lethal Response™ Preparedness
Apr 22, 2026
Jordan Park
Press Releases

Las Vegas Metropolitan Police Signs Five-Year WrapReality™ Contract Renewal with WRAP® to Advance Immersive Training and Non-Lethal Response™ Preparedness

Wrap Technologies, Inc. announced a five-year contract renewal with the Las Vegas Metropolitan Police Department for continued deployment and support of its WrapReality immersive virtual reality training platform. This strategic renewal highlights the police department's endorsement of the platform's value in enhancing officer decision-making, de-e…

WRAP
Enphase Energy Expands VPP Capabilities in Australia with Evergen
Apr 22, 2026
Jordan Park
Press Releases

Enphase Energy Expands VPP Capabilities in Australia with Evergen

Enphase Energy announced an integration between its IQ Batteries and Evergen's advanced virtual power plant (VPP) orchestration platform, enhancing Australian homeowners' ability to optimize battery use, participate in grid-support programs, and benefit from various state and federal incentives. This collaboration aims to accelerate battery adoptio…

ENPH
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
Apr 22, 2026
Derek Hwang
Press Releases

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

OPKO Health’s subsidiary, ModeX Therapeutics, has begun dosing patients in a Phase 1 clinical trial for MDX2003, a first-in-class tetraspecific T-cell engager antibody designed to treat relapsed or refractory B-cell lymphoma. MDX2003 targets two tumor antigens (CD19 and CD20) along with T-cell activators (CD3 and CD28) to enhance the immune system’…

OPK
The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform
Apr 22, 2026
Derek Hwang
Press Releases

The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform

The Beauty Health Company announced a corporate rebrand to SkinHealth Systems Inc. with the aim of becoming a clinically driven, science-backed medical aesthetics company. The company will continue trading under the ticker SKIN and focus on growing its skin health ecosystem anchored by its flagship Hydrafacial device along with complementary offeri…

SKIN
PMV Pharmaceuticals Announces Board Chair Transition
Apr 22, 2026
Maya Rios
Press Releases

PMV Pharmaceuticals Announces Board Chair Transition

PMV Pharmaceuticals has appointed Laurie Stelzer as the new Chair of its Board, succeeding Dr. Rich Heyman, effective after the 2026 Annual Meeting. This leadership transition coincides with the continuation of the PYNNACLE Phase 2 clinical trial of rezatapopt for TP53 Y220C mutated advanced solid tumors, with a planned NDA submission in early 2027…

PMVP
Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026
Apr 22, 2026
Ajmal Hussain
Press Releases

Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026

Madrigal Pharmaceuticals announced it will release its first-quarter 2026 financial results on May 6, 2026, before the US financial market opens. The company will host a live webcast to discuss the financial and operating results. Madrigal is focused on developing therapies for metabolic dysfunction-associated steatohepatitis (MASH), including the …

MDGL
Stereotaxis Announces First MAGiC Procedures in the United States
Apr 22, 2026
Avery Klein
Press Releases

Stereotaxis Announces First MAGiC Procedures in the United States

Stereotaxis announced successful completion of the first US procedures using its MAGiC robotically-navigated magnetic cardiac ablation catheter, recently approved by the FDA. The MAGiC catheter is designed to treat arrhythmias in patients with complex congenital heart abnormalities, improving precision and outcomes where manual catheters failed. Th…

STXS
Arq Schedules First Quarter 2026 Earnings Conference Call
Apr 22, 2026
Hana Yamamoto
Press Releases

Arq Schedules First Quarter 2026 Earnings Conference Call

Arq, Inc., a U.S. producer of activated carbon and environmentally efficient carbon products, announced it will release its first quarter 2026 financial results on May 6, followed by an earnings conference call on May 7. The company is the only vertically integrated activated carbon producer in North America, focusing on environmental technology so…

ARQ